相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to Chock for measure serum antibodies against pneumococcal serotype-specific polysaccharides
Muriel Feyssaguet et al.
VACCINE (2019)
Immunogenicity testing of therapeutic antibodies in ocular fluids after intravitreal injection
Uwe Wessels et al.
BIOANALYSIS (2018)
Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessments
Robert J. Kubiak et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1-small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)
Jan Welink et al.
BIOANALYSIS (2018)
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3-LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
Lauren Stevenson et al.
BIOANALYSIS (2018)
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2-PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)
Hendrik Neubert et al.
BIOANALYSIS (2018)
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
Celine Vandamme et al.
HUMAN GENE THERAPY (2017)
Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation
Uwe Wessels et al.
BIOANALYSIS (2017)
2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: immunogenicity, biomarkers and PK assays)
Shalini Gupta et al.
BIOANALYSIS (2017)
The Decennial Index of the White Papers in Bioanalysis: 'A Decade of Recommendations (2007-2016)'
Wei Garofolo et al.
BIOANALYSIS (2017)
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)
Hendrik Neubert et al.
BIOANALYSIS (2017)
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1-LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink et al.
BIOANALYSIS (2017)
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Pre-existing Antibody: Biotherapeutic Modality-Based Review
Boris Gorovits et al.
AAPS JOURNAL (2016)
On the Dependency of Cellular Protein Levels on mRNA Abundance
Yansheng Liu et al.
CELL (2016)
Recommendations for the development and validation of flow cytometry-based receptor occupancy assays
Cherie L. Green et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
Role of receptor occupancy assays by flow cytometry in drug development
Jennifer J. Stewart et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox
Amy K. Schneider et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3-LBA, biomarkers and immunogenicity)
Susan Richards et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1-small molecules, peptides and small molecule biomarkers by LCMS)
Eric Yang et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2-Hybrid LBA/LCMS and input from regulatory agencies)
An Song et al.
BIOANALYSIS (2016)
Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays
Robert J. Kubiak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
The evolution of guidelines for the validation of flow cytometric methods
L. Du et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development
Lynette Brown et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays
Jad Zoghbi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Effects of blood processing and sample storage on the stability of biotherapeutics and anti-drug antibodies
Matthew Andisik et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2-hybrid LBA/LCMS and input from regulatory agencies)
Brad Ackermann et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1-small molecules by LCMS)
Jan Welink et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3-LBA, biomarkers and immunogenicity)
Lakshmi Amaravadi et al.
BIOANALYSIS (2015)
Statistical Evaluation of Several Methods for Cut-Point Determination of Immunogenicity Screening Assay
Meiyu Shen et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2015)
Ligand Binding Assay Critical Reagents and Their Stability: Recommendations and Best Practices from the Global Bioanalysis Consortium Harmonization Team
Lindsay E. King et al.
AAPS JOURNAL (2014)
Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics
Boris Gorovits et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1-small molecules by LCMS)
Eric Fluhler et al.
BIOANALYSIS (2014)
Stability of anti-immunotherapeutic antibodies in frozen human serum samples
Lydia Michaut et al.
BIOANALYSIS (2014)
EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studies
Susanne Pihl et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2-hybrid LBA/LCMS, ELN & regulatory agencies' input)
Dawn Dufield et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3-LBA and immunogenicity)
Lauren Stevenson et al.
BIOANALYSIS (2014)
Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assays
Lauren F. Stevenson et al.
BIOANALYSIS (2014)
Validation of Cell-based Fluorescence Assays: Practice Guidelines from the ICSH and ICCS - Part V - Assay Performance Criteria
Brent Wood et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays
Robert J. Kubiak et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS
Lauren Stevenson et al.
BIOANALYSIS (2013)
Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents
Denise M. O'Hara et al.
AAPS JOURNAL (2012)
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
Binodh DeSilva et al.
BIOANALYSIS (2012)
Interactions of formulation excipients with proteins in solution and in the dried state
Satoshi Ohtake et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
Cherie L. Green et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Recommendations for the validation of flow cytometric testing during drug development: II assays
Denise M. O'Hara et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents
Roland F. Staack et al.
BIOANALYSIS (2011)
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections
Fabio Garofolo et al.
BIOANALYSIS (2011)
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance
Natasha Savoie et al.
BIOANALYSIS (2010)
2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop
Natasha Savoie et al.
BIOANALYSIS (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis
Natasha Savoie et al.
BIOANALYSIS (2009)
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
S. Janetzki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA
Holly W. Smith et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
An affinity capture elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug
James S. Bourdage et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
分享论文
